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REPORT
Visual short-term memory deficits in REM
sleep behaviour disorder mirror those in
Parkinson’s disease
Michal Rolinski,1,2,* Nahid Zokaei,3,4,* Fahd Baig,1,2 Kathrin Giehl,5 Timothy Quinnell,6
Zenobia Zaiwalla,7 Clare E. Mackay,1,3 Masud Husain,2,4,# and Michele T. M. Hu1,2,#
*,#These authors contributed equally to this work.
Individuals with REM sleep behaviour disorder are at signiﬁcantly higher risk of developing Parkinson’s disease. Here we exam-
ined visual short-term memory deﬁcits—long associated with Parkinson’s disease—in patients with REM sleep behaviour disorder
without Parkinson’s disease using a novel task that measures recall precision. Visual short-term memory for sequentially presented
coloured bars of different orientation was assessed in 21 patients with polysomnography-proven idiopathic REM sleep behaviour
disorder, 26 cases with early Parkinson’s disease and 26 healthy controls. Three tasks using the same stimuli controlled for
attentional ﬁltering ability, sensorimotor and temporal decay factors. Both patients with REM sleep behaviour disorder and
Parkinson’s disease demonstrated a deﬁcit in visual short-term memory, with recall precision signiﬁcantly worse than in healthy
controls with no deﬁcit observed in any of the control tasks. Importantly, the pattern of memory deﬁcit in both patient groups was
speciﬁcally explained by an increase in random responses. These results demonstrate that it is possible to detect the signature of
memory impairment associated with Parkinson’s disease in individuals with REM sleep behaviour disorder, a condition associated
with a high risk of developing Parkinson’s disease. The pattern of visual short-term memory deﬁcit potentially provides a cognitive
marker of ‘prodromal’ Parkinson’s disease that might be useful in tracking disease progression and for disease-modifying inter-
vention trials.
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Introduction
Prodromal Parkinson’s disease—the period between the
onset of neurodegeneration and diagnosis—is likely to be
the optimal time for introduction of potential curative or
disease-modifying treatments. It is associated with several
symptoms, including cognitive ones, which might provide a
means for early detection of Parkinson’s disease. However,
because screening for such deﬁcits on a population-wide
basis is challenging and unlikely to be a viable strategy, a
better understanding of prodromal Parkinson’s disease
might emerge from targeting ‘enriched’ at-risk cohorts in-
stead (Berg et al., 2012).
One such group is individuals with idiopathic rapid eye
movement (REM) sleep behaviour disorder, commonly
referred to as RBD. RBD is a parasomnia characterized
by motor behaviours associated with vivid dreams during
REM sleep (Boeve, 2010). Prospective cohort studies have
observed a very strong association between idiopathic RBD
and subsequent clinically deﬁned neurodegenerative disease,
with up to 80% of cases affected (Postuma et al., 2009;
Boot et al., 2012; Schenck et al., 2013). While some pa-
tients develop dementia with Lewy bodies or multiple
system atrophy, most eventually develop Parkinson’s dis-
ease (Boeve, 2010). This high risk of conversion makes
patients with RBD ideal candidates for neuroprotective
trials against Parkinson’s disease (Postuma et al., 2015).
A few studies have reported cognitive deﬁcits in RBD,
including modest or no impairments on short-term or
working memory tests that measure ‘span’ or number of
items that individuals can retain (Massicotte-Marquez
et al., 2008; Fantini et al., 2011). However, traditional
span measures rely on a binary response: either something
is remembered correctly or it is not. But just because an
individual fails to recall an item does not necessarily mean
that it was completely lost from memory. Recently, an al-
ternative theoretical and empirical approach has been de-
veloped to investigate the resolution or precision with
which items are retained. Rather than simply asking
whether an item is remembered or not (for a review see
Ma et al., 2014), this approach provides a more sensitive
measure of visual short-term memory (VSTM) performance
than span, including in patients with Parkinson’s disease
(Zokaei et al., 2015).
Importantly, tasks that measure precision of recall also
provide a means to dissect out sources of error contributing
to the pattern of performance using modern statistical tech-
niques (Bays et al., 2009). While it is known that many types
of brain disorder can be associated with VSTM deﬁcits, this
might be due to different underlying mechanisms in different
groups. In a recent study employing the same paradigm as
used here, dissociable signature deﬁcits associated with glu-
cocerebrosidase (GBA) mutations—the highest known gen-
etic risk factor for developing Parkinson’s disease—and
sporadic Parkinson’s disease were reported (Zokaei et al.,
2014). Speciﬁcally, while GBA-positive individuals showed
increased misbinding errors (reﬂecting interference between
items stored in memory), cases with sporadic Parkinson’s
disease demonstrated increased random errors (guesses).
GBA-positive cases with Parkinson’s disease showed both
types of error. Crucially, there was no evidence that GBA-
positive individuals without Parkinson’s disease have the
same type of memory impairment as those with
Parkinson’s disease. Here, we assessed VSTM in idiopathic,
GBA-negative cases with RBD—who have a much higher
risk of developing Parkinson’s disease than GBA-positive
subjects—and asked whether any deﬁcit in their memory
mirrors the pattern observed in patients with established,
sporadic GBA-negative Parkinson’s disease.
Subjects and methods
Participants
Twenty-one patients with RBD were recruited from sleep
clinics at the John Radcliffe Hospital, Oxford and Papworth
Hospital, Cambridge. The diagnosis of RBD was made on the
basis of clinical and polysomnographic evidence, according to
standard International Classiﬁcation of Sleep Disorders-II cri-
teria (Lapierre and Montplaisir, 1992). RBD was deﬁned as an
increase in tonic or phasic chin EMG activity during REM
sleep and either history of elaborate motor activity associated
with dream content, or the characteristic behavioural manifest-
ations occurring in REM sleep during polysomnographic
recordings. Patients were excluded if their RBD was judged
by their clinical team to be secondary to medication use or
associated with other neurological conditions, including
Parkinson’s disease and narcolepsy.
Fifteen non-medicated and 11 medicated patients with
Parkinson’s disease, as well as 26 age-matched healthy individ-
uals participated (see Table 1 for participants’ demographics).
Ethical approval was given by the Oxford University Research
Ethics Committee. Patients with Parkinson’s disease were re-
cruited if they met the UK Parkinson’s Disease Society Brain
Bank criteria for the diagnosis of idiopathic Parkinson’s dis-
ease (Hughes et al., 1992). All participants had normal or
corrected-to-normal vision and normal colour vision. All pa-
tients with RBD and Parkinson’s disease were screened for
common GBA mutations (Supplementary material) and con-
trol participants had no neurological disease or family history
of Gaucher’s disease. All cases with Parkinson’s disease and
RBD reported here were conﬁrmed GBA-negative.
Visual short-term memory task
The 4-item VSTM task was identical to that previously used
by Zokaei et al. (2014) (Fig. 1A). Brieﬂy, in each trial a se-
quence of four coloured bars of different orientation appeared
on the screen centre and participants were asked to remember
both the colour and orientation of the bars. At the end of each
sequence, a randomly oriented probe bar of the same colour as
one of the bars in the sequence was presented at screen centre.
Participants were instructed to use a rotating dial to match the
orientation of same coloured bar in the sequence. They clicked
on the dial to conﬁrm their selected orientation. Stimuli
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presented in any of the serial positions within the sequence
were probed with equal probability and participants did not
know beforehand which item would later be probed.
Control tasks
Poor performance in the VSTM task might be attributed to
factors other than the ability to maintain multiple items. To
ensure various issues were not a concern for subsequent inter-
pretation, three control tasks were administered: (i) pre-cueing:
an identical design to the 4-item VSTM task but with 100%
informative cues which tell the participant which colour will
be probed; (ii) one-item VSTM with variable delays (Fig. 1B)
to match durations between the probed item and appearance
of the probe in VSTM task; (iii) sensorimotor task (Fig. 1C):
participants simply match the orientation of a continuously
presented bar using the response dial.
These tasks are identical to those previously used by Zokaei
et al. (2014) and aim to control for deﬁcits in attentional ﬁl-
tering, temporal decay of information and difﬁculties with dex-
terity in using the dial, respectively.
All tasks were presented on a laptop (32  19) at 52 cm,
in random order across participants. For each of the experi-
mental VSTM, pre-cueing and 1-item VSTM tasks healthy
controls completed 100–200 trials, patients with RBD com-
pleted 100 trials and patients with Parkinson’s disease
Figure 1 Task to measure precision of recall. (A) A sequence of four coloured oriented bars were presented sequentially. Any of the bars
could be probed by colour of the response stimuli and participants were asked to adjust the orientation of the probed bar to the orientation of
the bar with same colour (red in this example). (B) One-item working memory task. A rotating dial is used to orient the probe bar (surrounded
by circle) to match the orientation of the probed bar presented following a delay. (C) Sensorimotor task. A rotating dial is used to orient the
probe bar to match the orientation of the target bar presented above the probe and continuously on view.
Table 1 Demographic information on all patient groups and healthy controls
Healthy controls
(n = 26)
RBD patients
(n = 21)
PD patients (n = 26) Medicated
PD (n = 11)Non-medicated (n = 15)
Age 66 (7) 66 (9) 65 (7) 67 (6)
Gender (M/F) 18/8 19/2 9/6 6/5
Years of education 14.7 (3.3) 14.6 (3.5) 15 (3.4) 14 (3)
MMSE 29 (1.1) 27.8 (1.5) 28.9 (0.9) 28.0 (1.3)
Years of diagnosis n/a 2.7 (1.9) 0.66 (0.74) 2.7 (1.3)
Daily levodopa equivalent dose n/a n/a n/a 355 (152)
UPDRS III n/a n/a 13 (4) 15 (3)
Values are mean (SD). MMSE = Mini-Mental State Examination; n/a = not applicable; PD = Parkinson’s disease.
UPDRS = Unified Parkinson’s Disease Rating Scale.
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completed 50–200 trials depending on their availability. All
patients with Parkinson’s disease and RBD as well as 17
healthy controls completed 20 trials of the sensorimotor con-
trol task.
Analysis
Recall precision was used as an overall measure of perform-
ance, calculated simply as the reciprocal of the circular stand-
ard deviation of response error (difference in response and
target angle), with less variability corresponding to a more
precise memory.
To identify mechanisms underlying VSTM impairments
associated with RBD and Parkinson’s disease, we ﬁt a prob-
abilistic model that dissociates different sources of error in
memory (Bays et al., 2009). In tasks similar to the one em-
ployed here, several sources of error can contribute to im-
paired performance (Ma et al., 2014). Error can arise due to
(i) increased variability in memory for the orientation of the
probed (target) item; (ii) increase in random responses; or (iii)
systematic interference by other items retained in VSTM—
these are responses centred on other, non-probed items in
the memory array (‘misbinding’ errors; see Supplementary
Fig. 1 for a schematic presentation of the model). Maximum
posteriors for three sources of error were estimated using the
MemToolbox (Suchow et al., 2013) (memtoolbox.org).
Results
There was no signiﬁcant difference in age and years of
education between the three groups. However, both pa-
tients with RBD and Parkinson’s disease scored signiﬁ-
cantly worse than healthy controls on the Mini-Mental
State Examination (MMSE) (Mann-Whitney U = 131,
P = 0.002 and U = 232.5, P = 0.042, respectively), although
on average both groups scored higher than 27 (a cut-off for
mild cognitive impairment) on this measure. Furthermore,
there was no signiﬁcant correlation between MMSE
and any of the measures of interest reported below.
Speciﬁcally there was no signiﬁcant correlation between
MMSE and proportion of random responses either within
each patient group or the combined group of participants.
VSTM impairments in cases with
RBD and Parkinson’s disease
There was no difference in overall VSTM performance be-
tween non-medicated and medicated patients with
Parkinson’s disease and hence these two groups were col-
lapsed for analysis (n = 26). ANOVA with serial position of
probe as within subject factor and group as between sub-
ject factor yielded a main effect of group [F(2,70) = 6.3,
P = 0.003]; compared to healthy participants, overall per-
formance was signiﬁcantly worse (i.e. less precise) in pa-
tients with RBD [t(42.4) = 2.3, P = 0.025] as well as cases
with Parkinson’s disease [t(40.7) = 3.2 P = 0.003, Fig. 2B].
Moreover, there was a signiﬁcant effect of serial position
on recall precision, showing the well-known effect of re-
cency [degrees of freedom were corrected using
Greenhouse-Geisser estimate; F(1.53,107) = 66, P5 0.001].
Sources of error in VSTM
Although both patient groups performed worse than
healthy participants, the overall VSTM performance is
Figure 2 Performance in the VSTM task. (A) Overall recall precision in both patient groups was significantly worse compared to healthy
controls. (B) This occurred at all serial positions of the probed item. PD = Parkinson’s disease.
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not informative of the source of error—the pattern of def-
icit—in these disorders. To quantify the possible sources of
error, we next applied a statistical mixture model of re-
sponses error. The results demonstrated no effect of
group on variability in memory for the probed orientation
(Fig. 3A) or on proportion of misbinding errors (Fig. 3B).
However, there was a signiﬁcant effect on proportion of
random responses [Welch’s adjusted F ratio: F(2,36) = 8.8
P = 0.001]. Compared to healthy controls, both patients
with RBD and Parkinson’s disease made signiﬁcantly
more random responses [t(33.9) = 3.7, P = 0.001 and
t(23.8), P = 0.024, respectively]. This was accompanied by
a signiﬁcant main effect of group on proportion of re-
sponses to the probed item [F(2,72) = 5.2, P = 0.008].
There was no signiﬁcant difference in all model estimates,
between patients with Parkinson’s disease and RBD.
Performance in control tasks
There were no signiﬁcant differences in performance on the
sensorimotor control task between the three groups
(Fig. 1C). This is important in excluding impaired dexterity
as a confounding factor in the 4-item VSTM task results,
particularly for the Parkinson’s disease group. There were
also no signiﬁcant differences between the patient groups
and healthy controls in the pre-cueing and 1-item (Fig. 1B)
VSTM tasks. Any signiﬁcant effect observed in the 4-item
VSTM task therefore cannot be attributed simply to deﬁcits
in attending to items presented sequentially or in temporal
decay of information. These ﬁndings also make it unlikely
that excessive sleepiness in RBD is the reason for the deﬁcit
observed on the 4-item VSTM task.
Discussion
The ﬁndings presented here demonstrate for the ﬁrst time,
to the best of our knowledge, that patients with RBD—at
high risk for developing Parkinson’s disease—show deﬁcits
in VSTM identical to those observed in Parkinson’s disease.
Speciﬁcally, deﬁcits in recall precision in both patient
groups are due to random corruption of memory, suggest-
ing that they share the same underlying impairment in
memory. The results of control experiments show that
this is independent of sensorimotor deﬁcits, difﬁculties in
attending to different serial positions in a sequence or tem-
poral decay of information, which makes it unlikely that
excessive sleepiness in RBD is the reason for the deﬁcit
observed on the 4-item VSTM task.
Importantly, the paradigm used here allowed us to ana-
lyse the sources of error in performance (Ma et al., 2014).
Recall error can ﬁrstly arise due to increase in variability in
memory for the probed feature, that is, how well the
probed feature is reproduced. Secondly, participants may
make random responses, guessing the orientation of the
probed bar, possibly due to failures at encoding or re-
trieval. Lastly, VSTM precision may be affected by mis-
binding errors. Unlike random responses, misbinding
errors have been linked to hippocampal and medial
temporal lobe pathology, including Alzheimer’s disease
(Parra et al., 2009; Pertzov et al., 2013) and mutations in
GBA (Zokaei et al., 2014).
Individuals with Parkinson’s disease made signiﬁcantly
more random responses than controls, but importantly
not signiﬁcantly more misbinding errors, replicating
and strengthening previous ﬁndings using this task
Figure 3 Model estimates for different sources of error in VSTM performance. (A) Concentration parameter (k) did not differ
significantly between patient groups and controls. (B) Probability of non-probed responses (misbinding errors) did not differ between groups.
(C) Probability of random responses was significantly higher in both patients with Parkinson’s disease (PD) and RBD compared to controls.
Short-term memory in RBD BRAIN 2016: 139; 47–53 | 51
Downloaded from https://academic.oup.com/brain/article-abstract/139/1/47/2468817
by University of Bristol Library user
on 08 December 2017
(Zokaei et al., 2014). The same pattern of results was also
present in patients with RBD. Although the precise mech-
anism underlying this type of error is yet to be established,
it might be due to increased noise within neuronal net-
works involved in encoding or maintaining information.
This could potentially arise due to cholinergic disruption
in Parkinson’s disease (Kehagia et al., 2010; Hasselmo
and Sarter, 2011) with associated ﬂuctuations in attention
leading to encoding or retrieval failure and therefore gues-
sing on some trials (Hasselmo and Sarter, 2011). Increased
random responses could also be a consequence of dopamin-
ergic dysfunction, associated with lower neural signal-to-
noise ratio (Sawaguchi and Goldman-Rakic, 1991;
Kroener et al., 2009). Indeed, improvements in VSTM per-
formance on this task have now been reported in patients
with Parkinson’s disease treated with dopaminergic drugs
(Zokaei et al., 2015).
Dysfunction within both cholinergic and dopaminergic
systems has now been reported in RBD before the onset
of clinically deﬁned neurodegenerative disease. Single-
photon emission computed tomography (SPECT) has
demonstrated decreased 123I-FP-CIT uptake in the striatum
of cases with RBD, with 40% of patients having an ab-
normal scan (Selikhova et al., 2009). Similarly, decreased
11C-dihydrotetrabenazine (11C-DTBZ) striatal binding on
PET scanning points to loss of dopaminergic neurons in
RBD (Ferini-Strambi et al., 2004). Although evidence for
cholinergic dysfunction is scarcer, one PET study has re-
vealed reduced acetylcholinesterase activity in RBD (Valerio
et al., 2013).
A number of previous studies have reported cognitive
impairment in RBD (Ferini-Strambi et al., 2004;
Massicotte-Marquez et al., 2008; Terzaghi et al., 2008),
which has been shown to be progressive (Fantini et al.,
2011). Moreover, the presence of RBD in established
Parkinson’s disease is associated with increased frequency
of cognitive impairment (Rolinski et al., 2014), and greater
risk of dementia (Postuma et al., 2012). These pioneering
studies have assessed several cognitive domains in RBD,
but the mechanisms underlying the observed impairments
and their relationship to sporadic Parkinson’s disease
remain poorly understood. The more focused approach
used here implicates a similar mechanism underlying
VSTM deﬁcits in Parkinson’s disease and RBD.
Importantly, as patients with RBD were not impaired in
any of the control experiments, sleep disturbances in
these patients is unlikely to explain the pattern of results.
It is possible that increased random responses on the
VSTM task might reﬂect a general cognitive decline in
both patients with Parkinson’s disease and RBD.
However, we did not ﬁnd any signiﬁcant correlation with
MMSE scores.
The results presented here in RBD are in contrast to
those found in individuals with GBA mutations, who
carry the strongest genetic risk factor for developing
Parkinson’s disease (Neumann et al., 2009; Sidransky
et al., 2009). On the paradigm used here, it has previously
been shown that asymptomatic GBA-positive individuals
are more likely to make misbinding errors than controls
(Zokaei et al., 2014). Their pattern of deﬁcit is different
to that of cases with Parkinson’s disease who show
increased random corruption of VSTM. Patients with
Parkinson’s disease who are also GBA-positive appear to
have a double hit, showing both increased misbinding and
random corruption of VSTM (Zokaei et al., 2014).
Although Parkinson’s disease is a heterogeneous condition
and there might not be a ‘typical’ phenotype (Selikhova
et al., 2009), our results suggest that RBD is more repre-
sentative of prodromal stages of sporadic Parkinson’s dis-
ease than GBA because both RBD and Parkinson’s disease
are associated with the same type of VSTM deﬁcit. Hence
RBD might be a better candidate disorder for clinical trials
of novel disease-modifying interventions in Parkinson’s dis-
ease, potentially using the pattern of impairment identiﬁed
here as a cognitive marker for incipient Parkinson’s disease
in this group. Longitudinal studies are required to assess
the feasibility of such an approach.
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